Literature DB >> 11129633

Hepatitis C virus variability: sequence analysis of an isolate after 10 years of chronic infection.

K Rispeter1, M Lu, S E Behrens, C Fumiko, T Yoshida, M Roggendorf.   

Abstract

Hepatitis C virus (HCV) variability was analyzed based upon an isolate which had caused the infection of more than 2500 women in 1978/79. Genome consensus sequences of two isolates obtained from the infectious source (HCV-AD78) and from a chronic hepatitis patient 10 years after the acute infection were determined. The entire open reading frame (ORF) exhibited 3.2 x 10(-3) nucleotide substitutions per site per year (deltant). Core (0.7 x 10(-3) deltant) and NS5B (1.9 x 10(-3) deltant) were found to be most conserved genes, while E2 (4.7 x 10(-3) deltant) with hypervariable region 1 (HVR1) (23 x 10(-3) deltant) was the most variable followed by p7 (4.2 x 10(-3) deltant). In the entire ORF transitions were 4.5 times more frequent than transversions while for the HVR1 this bias was turned. As an indicator of relative selective pressure on the proteins the rates of nonsynonymous to synonymous substitutions (dN/dS) were determined. The obtained values exceeded 1.0 only for E2 (dN/dS = 1.3). A subdivision of the entire ORF into 88 overlapping sections, each containing 300 nucleotides, led to a more precise analysis of HCV diversity. Besides for E2 an increased variability was mainly detected for three other regions: (a) the C terminal neighbouring region of E2 including p7, (b) the genome fragment extending from approximately the middle of NS3 to NS4B, and (c) the segment corresponding to the C-terminus of the NS5A protein. The variable region in NS5A was situated carboxyterminal to the predicted interferon sensitivity determining region (ISDR). These results suggest which regions other than HVR1 might contribute to persistence of the virus by the mechanism of immunescape.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129633     DOI: 10.1023/a:1008135413215

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  31 in total

1.  Marked sequence diversity in the putative envelope proteins of hepatitis C viruses.

Authors:  N Kato; Y Ootsuyama; T Tanaka; M Nakagawa; T Nakazawa; K Muraiso; S Ohkoshi; M Hijikata; K Shimotohno
Journal:  Virus Res       Date:  1992-02       Impact factor: 3.303

Review 2.  To C or not to C: these are the questions.

Authors:  H J Alter
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

3.  Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus.

Authors:  M E Major; K Mihalik; J Fernandez; J Seidman; D Kleiner; A A Kolykhalov; C M Rice; S M Feinstone
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.

Authors:  L Q Zhang; P MacKenzie; A Cleland; E C Holmes; A J Brown; P Simmonds
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

Authors:  S Brambilla; G Bellati; M Asti; A Lisa; M E Candusso; M D'Amico; G Grassi; M Giacca; A Franchini; S Bruno; G Ideo; M U Mondelli; E M Silini
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

6.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

Authors:  N Enomoto; I Sakuma; Y Asahina; M Kurosaki; T Murakami; C Yamamoto; Y Ogura; N Izumi; F Marumo; C Sato
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

7.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.

Authors:  M Martell; J I Esteban; J Quer; J Genescà; A Weiner; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin.

Authors:  H Meisel; A Reip; B Faltus; M Lu; H Porst; M Wiese; M Roggendorf; D H Krüger
Journal:  Lancet       Date:  1995-05-13       Impact factor: 79.321

9.  Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.

Authors:  A Zibert; E Schreier; M Roggendorf
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

10.  Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity.

Authors:  V Lohmann; F Körner; U Herian; R Bartenschlager
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

View more
  13 in total

Review 1.  Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments.

Authors:  Philip Wintermeyer; Jack R Wands
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Synthetic antigens representing the antigenic variation of human hepatitis C virus.

Authors:  Kyung Hee Kang; Yasuhiro Yamamura; Maria P Carlos; Nicolas Karvelas; In-Sup Kim; Deepa Sunkara; Rebecca Rivera; Murray B Gardner; David E Anderson; Francisco Diaz-Mitoma; José Torres; Juan P Marquez
Journal:  Viral Immunol       Date:  2010-10       Impact factor: 2.257

3.  The wild-type hepatitis C virus core inhibits initiation of antigen-specific T- and B-cell immune responses in BALB/c mice.

Authors:  Wenbo Zhu; Yanzi Chang; Chunchen Wu; Qingxia Han; Rongjuan Pei; Mengji Lu; Xinwen Chen
Journal:  Clin Vaccine Immunol       Date:  2010-06-02

4.  Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.

Authors:  Shadi Salloum; Cesar Oniangue-Ndza; Christoph Neumann-Haefelin; Laura Hudson; Silvia Giugliano; Marc aus dem Siepen; Jacob Nattermann; Ulrich Spengler; Georg M Lauer; Manfred Wiese; Paul Klenerman; Helen Bright; Norbert Scherbaum; Robert Thimme; Michael Roggendorf; Sergei Viazov; Joerg Timm
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

Review 5.  Sequence diversity of hepatitis C virus: implications for immune control and therapy.

Authors:  Joerg Timm; Michael Roggendorf
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

6.  Rapid evolution of pandemic noroviruses of the GII.4 lineage.

Authors:  Rowena A Bull; John-Sebastian Eden; William D Rawlinson; Peter A White
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

7.  Cross-reactivity of hypervariable region 1 chimera of hepatitis C virus.

Authors:  Bing-Shui Xiu; Shi-Gan Ling; Xiao-Guo Song; He-Qiu Zhang; Kun Chen; Cui-Xia Zhu
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

8.  High prevalence of hepatitis C virus genotype 1b infection in a small town of Argentina. Phylogenetic and Bayesian coalescent analysis.

Authors:  Marcelo D Golemba; Federico A Di Lello; Fernando Bessone; Fabian Fay; Silvina Benetti; Leandro R Jones; Rodolfo H Campos
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

9.  Acute hepatitis C in a chronically HIV-infected patient: evolution of different viral genomic regions.

Authors:  Diego Flichman; Veronica Kott; Silvia Sookoian; Rodolfo Campos
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.

Authors:  Jan M Pestka; Mirjam B Zeisel; Edith Bläser; Peter Schürmann; Birke Bartosch; Francois-Loïc Cosset; Arvind H Patel; Helga Meisel; Jens Baumert; Sergei Viazov; Kay Rispeter; Hubert E Blum; Michael Roggendorf; Thomas F Baumert
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.